David L. Kerr

866 total citations
23 papers, 357 citations indexed

About

David L. Kerr is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, David L. Kerr has authored 23 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Rheumatology. Recurrent topics in David L. Kerr's work include Sarcoma Diagnosis and Treatment (7 papers), Bone Tumor Diagnosis and Treatments (5 papers) and Nuclear Materials and Properties (5 papers). David L. Kerr is often cited by papers focused on Sarcoma Diagnosis and Treatment (7 papers), Bone Tumor Diagnosis and Treatments (5 papers) and Nuclear Materials and Properties (5 papers). David L. Kerr collaborates with scholars based in United States, Canada and United Kingdom. David L. Kerr's co-authors include William C. Eward, Brian E. Brigman, Mark R. Daymond, Alexander L. Lazarides, Dan G. Blazer, Fei Long, G. Domizzi, Brian Dial, R Sainsbury and Marcus Richards and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David L. Kerr

23 papers receiving 350 citations

Peers

Countries citing papers authored by David L. Kerr

Since Specialization

Citations

This map shows the geographic impact of David L. Kerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Kerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Kerr more than expected).

Fields of papers citing papers by David L. Kerr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Kerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Kerr. The network helps show where David L. Kerr may publish in the future.

Co-authorship network of co-authors of David L. Kerr

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Kerr. A scholar is included among the top collaborators of David L. Kerr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Kerr. David L. Kerr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chondrocyte Invasion May Be a Mechanism for Persistent Staphylococcus Aureus Infection In Vitro 2024 ·Clinical Orthopaedics and Related Research ·Jerry Chang, David L. Kerr, (unknown), Thorsten M. Seyler	2
2	Peripheral Nerve Block Delays Mobility and Increases Length of Stay in Patients With Geriatric Hip Fracture 2023 ·Journal of the American Academy of Orthopaedic Surgeons ·(unknown), David L. Kerr, Daniel J. Cunningham, Billy I. Kim, (unknown), (unknown), Colleen M. Wixted, (unknown), Malcolm R. DeBaun, Mark J. Gage	1
3	Association Between Hospital Monopoly Status, Patient Socioeconomic Disadvantage, and Total Joint Arthroplasty Price Disclosure 2023 ·Journal of the American Academy of Orthopaedic Surgeons ·(unknown), (unknown), David L. Kerr, Melissa Erickson, Yuqi Zhang, Marcelo Cerullo	3
4	Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma 2020 ·Molecular Cancer Therapeutics ·Gireesh B. Reddy, David L. Kerr, Ivan Spasojević, Artak Tovmasyan, David S. Hsu, Brian E. Brigman, Jason A. Somarelli, David Needham, William C. Eward	20
5	The Role of Radiotherapy for Chordoma Patients Managed With Surgery 2020 ·Spine ·Brian Dial, David L. Kerr, Alexander L. Lazarides, Anthony A. Catanzano, Cindy L. Green, Thomas Risoli, Dan G. Blazer, (unknown), Brian E. Brigman, William C. Eward, Nicole Larrier, David G. Kirsch, Sergio Mendoza-Lattes	32
6	Does facility volume influence survival in patients with primary malignant bone tumors of the vertebral column? A comparative cohort study 2020 ·The Spine Journal ·Alexander L. Lazarides, David L. Kerr, Brian Dial, John R. Steele, Whitney O. Lane, Dan G. Blazer, Brian E. Brigman, Sergio Mendoza-Lattes, Melissa Erickson, William C. Eward	3
7	Phase Transformation and Atypical Variants in an Extruded Two Phase Zirconium Tube 2020 ·Metallurgical and Materials Transactions A ·David L. Kerr, (unknown), Mark R. Daymond	4
8	Revisiting the Role of Radiation Therapy in Chondrosarcoma: A National Cancer Database Study 2019 ·Sarcoma ·Anthony A. Catanzano, David L. Kerr, Alexander L. Lazarides, Brian Dial, Whitney O. Lane, Dan G. Blazer, Nicole Larrier, David G. Kirsch, Brian E. Brigman, William C. Eward	20
9	Epidemiologic and survival trends in adult primary bone tumors of the spine 2019 ·The Spine Journal ·David L. Kerr, Brian Dial, Alexander L. Lazarides, Anthony A. Catanzano, Whitney O. Lane, Dan G. Blazer, Brian E. Brigman, Sergio Mendoza-Lattes, William C. Eward, (unknown)	39
10	The Value of MRI in Distinguishing Subtypes of Lipomatous Extremity Tumors Needs Reassessment in the Era of MDM2 and CDK4 Testing 2018 ·Sarcoma ·Sean P. Ryan, Julia D. Visgauss, David L. Kerr, Joshua Helmkamp, Nicholas Said, Emily N. Vinson, Patrick W. O’Donnell, (unknown), Sin‐Ho Jung, Diana M. Cardona, William C. Eward, Brian E. Brigman	16
11	Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers? 2018 ·Clinical Orthopaedics and Related Research ·Alexander L. Lazarides, David L. Kerr, Daniel P. Nussbaum, (unknown), Jason A. Somarelli, Dan G. Blazer, Brian E. Brigman, William C. Eward	46
12	Crystallographic texture and microstructural changes in fusion welds of recrystallized Zry-4 rolled plates 2017 ·Journal of Nuclear Materials ·(unknown), M.A. Vicente Álvarez, J.R. Santisteban, P. Vizcaı́no, Silvina Limandri, Mark R. Daymond, David L. Kerr, John Okasinski, Jonathan Almer, Sven C. Vogel	10
13	Microstructure characterization of a hydride blister in Zircaloy-4 by EBSD and TEM 2017 ·Acta Materialia ·Fei Long, David L. Kerr, G. Domizzi, (unknown), Mark R. Daymond	45
14	Orientation relationships between α-zirconium and δ-hydride within a hydride blister 2017 ·Journal of Applied Crystallography ·David L. Kerr, Fei Long, G. Domizzi, Mark R. Daymond	11
15	Retrospective Clinical Study of Advanced Pancreatic Cancer Treated With Chemotherapy and Abdominal Hyperthermia 2017 ·Journal of Global Oncology ·(unknown), Yuan Qin, Dinggang Li, David L. Kerr	10
16	Toxic shock in children with bone and joint infections: A review of seven years of patients admitted to one intensive care unit 2017 ·Journal of Children s Orthopaedics ·David L. Kerr, (unknown), (unknown), Thomas V. Brogan, Gregory A. Schmale	6
17	Engaging Health Professional Students in Substance Abuse Research 2012 ·Journal of Addiction Medicine ·(unknown), Adina Kalet, Colleen Gillespie, Frederick G. More, Madeline A. Naegle, Joshua D. Lee, (unknown), David L. Kerr, Marc N. Gourevitch	16
18	Biochemical Characterization of P4-ATPase Mutations Identified in Patients with Progressive Familial Intrahepatic Cholestasis 2012 ·Journal of Biological Chemistry ·(unknown), (unknown), (unknown), Emily Foran, Mridu Kapur, (unknown), Nathan Belkin, David L. Kerr, (unknown), Patrick Williamson	16
19	Phase III trial of adjuvant immunotherapy with MOAb 17–1A following resection for stage II adenocarcinoma of the colon (CALGB 9581) 2004 ·Journal of Clinical Oncology ·Thomas A. Colacchio, Donna Niedzwiecki, Carolyn C. Compton, Richard Warren, (unknown), Richard M. Goldberg, David L. Kerr, Andrew T. Fields, Donna Hollis, Robert J. Mayer	12
20	Inequalities in breast cancer care and outcome 1997 ·British Journal of Cancer ·Marcus Richards, R Sainsbury, David L. Kerr	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact